These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 28815663)

  • 21. Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016.
    Sasaki H; Yoshida K
    Neurol Med Chir (Tokyo); 2017 Dec; 57(12):658-666. PubMed ID: 28845038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaplastic gliomas in adults: an update.
    Izquierdo C; Joubert B; Ducray F
    Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification.
    Ly KI; Wen PY; Huang RY
    Neurol Clin; 2020 Feb; 38(1):95-113. PubMed ID: 31761063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in subtyping tumors of the central nervous system using molecular data.
    Schittenhelm J
    Expert Rev Mol Diagn; 2017 Jan; 17(1):83-94. PubMed ID: 27893285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types.
    Reinhardt A; Pfister K; Schrimpf D; Stichel D; Sahm F; Reuss DE; Capper D; Wefers AK; Ebrahimi A; Sill M; Felsberg J; Reifenberger G; Becker A; Prinz M; Staszewski O; Hartmann C; Schittenhelm J; Gramatzki D; Weller M; Olar A; Rushing EJ; Bergmann M; Farrell MA; Blümcke I; Coras R; Beckervordersandforth J; Kim SH; Rogerio F; Dimova PS; Niehusmann P; Unterberg A; Platten M; Pfister SM; Wick W; Herold-Mende C; von Deimling A
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12847. PubMed ID: 35977725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours.
    Oliva MA; Staffieri S; Castaldo S; Giangaspero F; Esposito V; Arcella A
    J Neurooncol; 2021 Jan; 151(2):123-133. PubMed ID: 33398536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
    Kurokawa R; Kurokawa M; Baba A; Ota Y; Pinarbasi E; Camelo-Piragua S; Capizzano AA; Liao E; Srinivasan A; Moritani T
    Radiographics; 2022; 42(5):1474-1493. PubMed ID: 35802502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
    Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
    Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the impact of glioma diagnostic reclassification following the new 2016 WHO classification on a series of cases.
    Valera-Melé M; Mateo Sierra O; Sola Vendrell E; Guzmán de Villoria L JA; Carvajal Díaz L; Gil de Sagredo Del Corral ÓL; García Leal R
    Neurocirugia (Astur : Engl Ed); 2019; 30(1):19-27. PubMed ID: 30366644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Revised WHO classification of brain tumours].
    Nakazato Y
    Brain Nerve; 2008 Jan; 60(1):59-77. PubMed ID: 18232334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF; Prayson RA; Barnett GH; Weil RJ
    Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult type diffuse gliomas in the new 2021 WHO Classification.
    Antonelli M; Poliani PL
    Pathologica; 2022 Dec; 114(6):397-409. PubMed ID: 36534419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
    Wirsching HG; Weller M
    Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.